CClinicalTrials.gg
Sign In
Status unknownNCT04068870Updated Aug 28, 2019

Testing a Modified Family Planning Intervention for Postpartum Women in Uganda

A Phase 1 interventional study of Contraceptive management program in Contraceptive Usage, sponsored by University of Vermont. Status unknown at 1 site in Uganda. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-28.

Sponsored by University of Vermont · Phase 1, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Aug 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 1
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The purpose of this study is to test whether offering incentives to encourage women to attend one-on-one family planning education sessions and offering free, onsite prescription contraceptive methods increases use and continuation of prescription contraception among postpartum women in Uganda. This intervention is modified from one that has been effective outside of Uganda.

02

Conditions studied

  • Contraceptive Usage
03

In context

Lead sponsor

University of Vermont is the lead sponsor of 215 studies on the registry; 28 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 9 (56%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18-45 years of age
  • Not planning on getting pregnant in the next 4 months
  • Less than 3 months postpartum
  • No history of tubal ligation or hysterectomy
  • No recent prescription contraceptive use (no pill, intrauterine device or implant use in the past 7 days or injection use in the past 3 months)
  • Medically eligible to use prescription contraceptives
  • Bringing baby to immunization clinic for the first time

Exclusion criteria

Exclusion Criteria:

  • Failure to meet the aforementioned inclusion criteria
05

Study design

Phase
Phase 1
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Contraceptive management program

    Behavioral: Contraceptive management program

  • No intervention
    Usual care

Interventions

  • BehavioralContraceptive management program

    The contraceptive management program will consist of two components: (1) the World Health Organization's contraception protocol and (2) incentivized visits.

06

What researchers measure

Primary outcomes

  1. Period prevalence use of a prescription contraceptive

    Period prevalence use of a prescription contraceptive

    Time frame: 6 months after delivery

07

Study locations

1 of 1 sites recruiting
  • Nakaseke District Hospital
    Nakaseke, Uganda
    • John Mundaka, MD · Contact
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04068870
Lead sponsor
University of Vermont
Collaborators
African Community Center for Social Sustainability
Responsible party
Sarah Heil (Professor, University of Vermont) — Principal investigator
First posted
Aug 28, 2019
Start date
Aug 5, 2019
Primary completion
Apr 2020 (estimated)
Completion
Apr 2020 (estimated)
Last update
Aug 28, 2019

Study contacts

Sarah Heil, PhD
Contact
sarah.heil@uvm.edu
802-656-8712
Sarah Heil, PhD
principal investigator · University of Vermont

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

University of Vermont

Start the discussion